Company
T2D.com
T2D.com publishes compounded semaglutide and unspecified GLP-1, from $99 to $170 a month.
Published by Treatment Registry · Latest research
- 2 programs
- 1 identified molecule
- 2 readings
Read from t2d.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.
Go to T2D.com
We earn nothing from this link. It opens T2D.com's website without a paid referral.
What it costs
first month, including required fees on record · Bring Your Own Prescription (BYOP)
first month, including required fees on record · Use Our Prescribers - Monthly, All-Inclusive
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Programs
Notes
Pricing details, service terms and questions to confirm before enrolling.
September 2026
- 1. T2D.com never names the drug for its main 'Use Our Prescribers' plan on the pricing block (elsewhere the site says it offers compounded Semaglutide and Tirzepatide generally), so that $170/mo entry is recorded as unspecified GLP-1. Form (vial vs pen) is never stated. About-us and contact-us paths 404'd; /pricing, /faq and /plans also 404'd -- pricing lives at /weight-loss instead.
Understand the terms
- Cancellation and refunds
Ending future billing and refunding an existing order are separate questions.
Before you act
Cite this
Treatment Registry. (2026). T2D.com: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/t2d